Entest Group Inc

[atglobe]

Concerned about employees engaged in the utilization of embryonic stem cells, I am maybe some what neutral to embryonic stem cells and possibly against it...

So I am concerned about investing in ENTB when I read something like this below from their website.



http://www.entb.net/team.html#mt
Ewa Carrier, M.D.
Associate Professor of Clinical Medicine and Pediatrics
University of California San Diego (UCSD)
Blood and Marrow Transplant Program
Dr. Carriers research focuses on stem cell biology and its transplantation to cancer and organ repair. She focuses on the properties of pluripotent stem cells, including embryonic, fetal, mesenchymal and bone marrow stem cells, to generate differentiation protocols for the treatment of a variety of disorders. Clinically, Dr. Carrier works on multiple protocols related to stem cell transplant for cancers, such as leukemias, lymphomas and multiple myeloma as well as autoimmune diseases. She participates in the protocols within the NIH-sponsored Clinical Trial Network, and is a member of NIH-funded national consortium to treat autoimmune diseases with stem cells.


I am tired...